Wai Ho Tang
- Cancer Research top 2%
- MicroRNA in disease regulation 3
- Molecular Biology top 5%
- Heme Oxygenase-1 and Carbon Monoxide 3
- Extracellular vesicles in disease 2
- Immunology top 10%
- Hematology top 10%
- Genetics top 10%
-
- Aldose Reductase and Taurine 5
-
- Antiplatelet Therapy and Cardiovascular Diseases 4
-
- Kawasaki Disease and Coronary Complications 3
-
- Cardiac Ischemia and Reperfusion 3
-
- Ferroptosis and cancer prognosis 2
- Co-authors
- Yunfeng LiuYuan ZhangHaiying LiuJohn HwaKathleen A. MartinRenjing LiuJeremiah StithamLuoxing Xia
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wai Ho Tang
26 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Cancer Research 1.1k
- Molecular Biology 2.1k
- Immunology 326
- Hematology 132
- Genetics 121
Countries citing papers authored by Wai Ho Tang
This map shows the geographic impact of Wai Ho Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wai Ho Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wai Ho Tang more than expected).
Fields of papers citing papers by Wai Ho Tang
This network shows the impact of papers produced by Wai Ho Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wai Ho Tang. The network helps show where Wai Ho Tang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wai Ho Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 30 | |
| 3 | 2022 | 3 | |
| 4 | 2022 | 11 | |
| 5 | 2022 | 50 | |
| 6 | 2020 | 9 | |
| 7 | 2020 | 15 | |
| 8 | Exosomes: biogenesis, biologic function and clinical potentialbreakdown → | 2019 | 1579 |
| 9 | 2019 | 95 | |
| 10 | 2018 | 26 | |
| 11 | 2016 | 96 | |
| 12 | 2016 | 98 | |
| 13 | 2015 | 79 | |
| 14 | 2014 | 93 | |
| 15 | 2013 | 7 | |
| 16 | 2012 | 33 | |
| 17 | 2011 | 36 | |
| 18 | 2010 | 65 | |
| 19 | 2009 | 42 | |
| 20 | 2008 | 71 |
About Wai Ho Tang
Wai Ho Tang is a scholar working on Cell Biology, Pathology and Forensic Medicine and Cancer Research, having authored 28 papers that have together received 3.0k indexed citations. Recurring topics across this work include Aldose Reductase and Taurine (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Kawasaki Disease and Coronary Complications (3 papers), MicroRNA in disease regulation (3 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers), Cardiac Ischemia and Reperfusion (3 papers), Extracellular vesicles in disease (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (2.1k citations) and Immunology (326 citations). Wai Ho Tang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yunfeng Liu, Yuan Zhang, Haiying Liu, John Hwa, Kathleen A. Martin, Renjing Liu, Jeremiah Stitham, Luoxing Xia, Zhi Zeng and Sookja Kim Chung. Their work appears in journals such as Circulation, Journal of Clinical Investigation and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.